Integral Molecular reaches milestone in I-O target discovery collaboration with Daiichi Sankyo

Integral Molecular, the industry leader in discovering antibodies against multipass membrane proteins, today announced that it has successfully reached the first milestone in its collaboration with Daiichi Sankyo Co., Ltd. to discover new immuno-oncology (I-O) therapeutic targets. Integral Molecular utilized its Membrane Proteome Array (MPA) platform to find novel protein targets that can regulate the…

Researchers identify traits linked to better outcomes in HPV-linked head and neck cancer

Using a new blood test that’s in development, University of North Carolina Lineberger Comprehensive Cancer Center researchers identified characteristics that could be used to personalize treatment for patients with a type of head and neck cancer linked to HPV infection. Researchers believe the findings, published in the journal Clinical Cancer Research, could help identify those…

Medical News Today: What to know about surgery for MS

Multiple sclerosis attacks the protective coating around the nerves throughout the body, including those in the brain. Multiple sclerosis is a progressive disease, which means that it typically becomes worse over time. As it progresses, a person often notices their movement, speech, and other bodily functions becoming impaired. Eventually, these impairments can become life-altering. According…